CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThe results of vaccination trials carried out on pups with maternally derived antibodies (MDA) to canine parvovirus (CPV), using a modified-live CPV-2b variant vaccine (29-97/40 strain), are reported. The vaccine was able to overcome the obstacle of MDA, and to elicit protective immunity in 100% of the pups whose antibody titres were 1:10-1:40, 83% of the pups with titres of 1:80, 57% of the pups with titres of 1:160, and even in 60% of the pups with antibody titres of 1:320.
Immunization of pups with maternally-derived antibodies to canine parvovirus (CPV) using a modified - live variant (CPV-2b) / PRATELLI A.; CAVALLI A; NORMANNO G.; DE PALMA M.G.; PASTORELLI G.; MARTELLA V.; BUONAVOGLIA C.. - In: JOURNAL OF VETERINARY MEDICINE. SERIES B. - ISSN 0931-1793. - 47(2000), pp. 273-276.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Immunization of pups with maternally-derived antibodies to canine parvovirus (CPV) using a modified - live variant (CPV-2b) |
| Autori: | |
| Data di pubblicazione: | 2000 |
| Rivista: | |
| Citazione: | Immunization of pups with maternally-derived antibodies to canine parvovirus (CPV) using a modified - live variant (CPV-2b) / PRATELLI A.; CAVALLI A; NORMANNO G.; DE PALMA M.G.; PASTORELLI G.; MARTELLA V.; BUONAVOGLIA C.. - In: JOURNAL OF VETERINARY MEDICINE. SERIES B. - ISSN 0931-1793. - 47(2000), pp. 273-276. |
| Abstract: | The results of vaccination trials carried out on pups with maternally derived antibodies (MDA) to canine parvovirus (CPV), using a modified-live CPV-2b variant vaccine (29-97/40 strain), are reported. The vaccine was able to overcome the obstacle of MDA, and to elicit protective immunity in 100% of the pups whose antibody titres were 1:10-1:40, 83% of the pups with titres of 1:80, 57% of the pups with titres of 1:160, and even in 60% of the pups with antibody titres of 1:320. |
| Handle: | http://hdl.handle.net/11586/122282 |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Copyright © 2021